Cargando…
A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): A review of clinical studies on weight loss and glycemic control
Obesity, and resultant health hazards which include diabetes, cardiovascular disease and metabolic syndrome, are worldwide medical problems. Control of diet and exercise are cornerstones of the management of excess weight. Foods with a low glycemic index may reduce the risk of diabetes and heart dis...
Autores principales: | Barrett, Marilyn L, Udani, Jay K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071778/ https://www.ncbi.nlm.nih.gov/pubmed/21414227 http://dx.doi.org/10.1186/1475-2891-10-24 |
Ejemplares similares
-
Systematic Review and Meta-Analysis of a Proprietary Alpha-Amylase Inhibitor from White Bean (Phaseolus vulgaris L.) on Weight and Fat Loss in Humans
por: Udani, Jay, et al.
Publicado: (2018) -
Lowering the glycemic index of white bread using a white bean extract
por: Udani, Jay K, et al.
Publicado: (2009) -
Subchronic Study of a White Kidney Bean (Phaseolus vulgaris) Extract with α-Amylase Inhibitory Activity
por: Qin, Guangqiu, et al.
Publicado: (2019) -
Heterologous expression of an α-amylase inhibitor from common bean (Phaseolus vulgaris) in Kluyveromyces lactis and Saccharomyces cerevisiae
por: Brain-Isasi, Stephanie, et al.
Publicado: (2017) -
Phaseolus vulgaris L. Extract: Alpha-Amylase Inhibition against Metabolic Syndrome in Mice
por: Micheli, Laura, et al.
Publicado: (2019)